We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Burgundy Technology Acquition Corporation | NASDAQ:BTAQ | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.04 | 10.04 | 10.05 | 0 | 01:00:00 |
|
Cayman Islands
|
| |
98-1580814
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(I.R.S. Employer
Identification Number) |
|
|
PO Box 1093
Boundary Hall, Cricket Square Grand Cayman, KY1-1102 Cayman Islands |
| |
N/A
|
|
|
(Address of principal executive offices)
|
| |
(Zip Code)
|
|
|
Title of Each Class:
|
| |
Trading Symbol(s)
|
| |
Name of Each Exchange on Which Registered:
|
|
|
Units, each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant
|
| |
BTAQU
|
| |
The NASDAQ Stock Market LLC
|
|
|
Class A Ordinary Shares, par value $0.0001 per share
|
| |
BTAQ
|
| |
The NASDAQ Stock Market LLC
|
|
|
Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
|
| |
BTAQW
|
| |
The NASDAQ Stock Market LLC
|
|
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☒
|
| |
Smaller reporting company
☒
|
|
|
Emerging growth company
☒
|
| | | |
| | |
PAGE
|
| | | | |||
| | | | 1 | | | | |||
| | | | 21 | | | | |||
| | | | 57 | | | | |||
| | | | 57 | | | | |||
| | | | 57 | | | | |||
| | | | 57 | | | | |||
PART II | | | | | | | | | ||
| | | | 58 | | | | |||
| | | | 58 | | | | |||
| | | | 58 | | | | |||
| | | | 63 | | | | |||
| | | | 63 | | | | |||
| | | | 63 | | | | |||
| | | | 63 | | | | |||
| | | | 64 | | | | |||
PART III | | | | | | | | | ||
| | | | 65 | | | | |||
| | | | 74 | | | | |||
| | | | 75 | | | | |||
| | | | 77 | | | | |||
| | | | 79 | | | | |||
PART IV | | | | | | | | | ||
| | | | 80 | | | | |||
| | | | 81 | | | |
Name
|
| |
Age
|
| |
Title
|
|
Leo Apotheker | | |
67
|
| | Co-Chief Executive Officer, Chairman of the Board and Director | |
Jim Mackey | | |
50
|
| |
Co-Chief Executive Officer, Chief Financial Officer, Secretary and Director
|
|
Franck Cohen | | |
61
|
| | Director | |
Hervé Couturier | | |
62
|
| | Director | |
Raj Dani | | |
51
|
| | Director | |
Melissa Di Donato Roos
|
| |
48
|
| | Director | |
Individual(1)(2)
|
| |
Entity
|
| |
Entity’s Business
|
| |
Affiliation
|
| |||
Leo Apotheker | | | P2 Energy Solutions | | | Software and Data | | | | | Director | | |
| | | Unit4 | | | Enterprise Software | | | | | Director | | |
| | | Syncron | | | Enterprise Software | | | | | Director | | |
| | | Taulia | | | Capital Management | | | | | Director | | |
| | | Schneider SE | | | Electrical Equipment | | | | | Director | | |
| | | Nice Ltd. | | | Enterprise Software | | | | | Director | | |
| | | Appway AG | | | Enterprise Software | | | | | Director | | |
Franck Cohen | | | Trackunit | | | Telematics | | | | | Chairman | | |
| | | Geektime | | | Online News Portal | | | | | Chairman | | |
| | | SUSE | | |
Open Source Software
|
| | | | Director | | |
| | | Antuit | | | Software and Data | | | | | Director | | |
| | | Acumatica | | | Software and Data | | | | | Director | | |
| | | Beqom | | | Enterprise Software | | | | | Director | | |
| | | Qvantel | | | Enterprise Software | | | | | Director | | |
| | | Omada | | | Software and Data | | | | | Director | | |
Hervé Couturier | | | Kerney Partners | | | Consulting | | | | | President | | |
| | | Sabre | | | Software and Data | | | | | Director | | |
| | | SimCorp A/S | | | Enterprise Software | | | | | Director | | |
| | | Infovista Inc. | | | Enterprise Software | | | | | Director | | |
| | | Unit4 | | | Enterprise Software | | | | | Director | | |
| | | Sportradar AG | | | Software and Data | | | | | Director | | |
| | | Kyriba Corp. | | | Software and Data | | | | | Director | | |
| | | Odigo SAS | | | Enterprise Software | | | | | Director | | |
Raj Dani | | |
Ping Identity Corporation
|
| | Software and Data | | | | | CFO | | |
Melissa Di Donato Roos | | | SUSE | | |
Open Source Software
|
| | | | CEO | | |
| | | Uccelli UK | | |
Technology Consulting
|
| | | | Director | | |
| | |
Class A Ordinary Shares
|
| |
Class B Ordinary Shares
|
| |
Approximate
Percentage of Outstanding Ordinary Shares |
| |||||||||||||||||||||
Name and Address of Beneficial Owner
|
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| ||||||||||||||||||
Burgundy Technology Sponsor Limited (our sponsor)(1)(2)
|
| | | | 1,062,500 | | | | | | 2.99% | | | | | | 8,625,000 | | | | | | 100% | | | | | | 21.92% | | |
Leo Apotheker(1)(2)
|
| | | | 1,062,500 | | | | | | 2.99% | | | | | | 8,625,000 | | | | | | 100% | | | | | | 21.92% | | |
Jim Mackey(1)(2)
|
| | | | 1,062,500 | | | | | | 2.99% | | | | | | 8,625,000 | | | | | | 100% | | | | | | 21.92% | | |
All officers and directors as a group (six individuals)
|
| | | | 1,062,500 | | | | | | 2.99% | | | | | | 8,625,000 | | | | | | 100% | | | | | | 21.92% | | |
Other 5% Shareholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Castle Creek Arbitrage, LLC(3)
|
| | | | 2,780,000 | | | | | | 7.82% | | | | | | — | | | | | | — | | | | | | 6.29% | | |
Magnetar Financial LLC(4)
|
| | | | 2,417,952 | | | | | | 6.80% | | | | | | — | | | | | | — | | | | | | 5.47% | | |
Linden Advisors LP(5)
|
| | | | 2,000,000 | | | | | | 5.62% | | | | | | — | | | | | | — | | | | | | 4.53% | | |
Citadel Advisors LLC(6)
|
| | | | 1,800,000 | | | | | | 5.06% | | | | | | — | | | | | | — | | | | | | 4.07% | | |
| | | | ||
| Financial Statements: | | | | |
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | |
|
Exhibit No.
|
| |
Description
|
|
| 1.1 | | | | |
| 3.1 | | | | |
| 4.1 | | | | |
| 4.2 | | | | |
| 4.3 | | | | |
| 4.4 | | | | |
| 4.5 | | | | |
| 10.1 | | | | |
| 10.2 | | | | |
| 10.3 | | | | |
| 10.4 | | | | |
| 10.5 | | | | |
| 10.6 | | | | |
| 10.7 | | | | |
| 14.1 | | | | |
| 31.1 | | | | |
| 31.2 | | | | |
| 32.1 | | | | |
| 32.2 | | | | |
| 101.INS | | | XBRL Instance Document* | |
| 101.SCH | | | XBRL Taxonomy Extension Schema* | |
| 101.CAL | | | XBRL Taxonomy Calculation Linkbase* | |
| 101.LAB | | | XBRL Taxonomy Label Linkbase* | |
| 101.PRE | | | XBRL Definition Linkbase Document* | |
| 101.DEF | | | XBRL Definition Linkbase Document* | |
| June 4, 2021 | | | Burgundy Technology Acquisition Corporation | | |||
| | | | By: | | |
/s/ Leo Apotheker
|
|
| | | | Name: | | | Leo Apotheker | |
| | | | Title: | | |
Chief Executive Officer
(Principal Executive Officer) |
|
Name
|
| |
Position
|
| |
Date
|
|
/s/ Leo Apotheker
Leo Apotheker
|
| |
Chief Executive Officer and Director
(Principal Executive Officer) |
| |
June 4, 2021
|
|
| | | | | | | |
/s/ James Scott Mackey
James Scott Mackey
|
| |
Chief Financial Officer and Director
(Principal Financial and Accounting Officer) |
| |
June 4, 2021
|
|
| | | | | | | |
/s/ Franck Cohen
Franck Cohen
|
| | Director | | |
June 4, 2021
|
|
| | | | | | | |
/s/ Hervé Couturier
Hervé Couturier
|
| | Director | | |
June 4, 2021
|
|
| | | | | | | |
/s/ Raj Dani
Raj Dani
|
| | Director | | |
June 4, 2021
|
|
| | | | | | | |
/s/ Melissa Di Donato Roos
Melissa Di Donato Roos
|
| | Director | | |
June 4, 2021
|
|
| | | | | | | |
| Assets | | | | | | | |
| Current assets: | | | | | | | |
|
Cash
|
| | | $ | 974,815 | | |
|
Prepaid expenses
|
| | | | 136,636 | | |
|
Total current assets
|
| | | | 1,111,451 | | |
|
Investments held in Trust Account
|
| | | | 346,736,767 | | |
|
Total assets
|
| | | $ | 347,848,218 | | |
| Liabilities and Shareholders’ Equity | | | | | | | |
| Current liabilities: | | | | | | | |
|
Accounts payable
|
| | | $ | 9,352 | | |
|
Accrued expenses
|
| | | | 80,000 | | |
|
Total current liabilities
|
| | | | 89,352 | | |
|
Derivative warrant liabilities
|
| | | | 34,081,880 | | |
|
Deferred underwriting commissions
|
| | | | 12,075,000 | | |
|
Total liabilities
|
| | | | 46,246,232 | | |
| Commitments and Contingencies | | | | | | | |
|
Class A ordinary shares, $0.0001 par value; 29,512,635 shares subject to possible redemption at $10.05 per share
|
| | | | 296,601,983 | | |
| Shareholders’ Equity: | | | | | | | |
|
Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
|
| | | | — | | |
|
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 6,049,865 shares
issued and outstanding (excluding 29,512,635 shares subject to possible redemption) |
| | | | 605 | | |
|
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding
|
| | | | 863 | | |
|
Additional paid-in capital
|
| | | | 20,885,583 | | |
|
Accumulated deficit
|
| | | | (15,887,048) | | |
|
Total shareholders’ equity
|
| | | | 5,000,003 | | |
|
Total Liabilities and Shareholders’ Equity
|
| | | $ | 347,848,218 | | |
| Operating expenses: | | | | | | | |
|
General and administrative expenses
|
| | | $ | 348,055 | | |
|
Loss from operations
|
| | | | (348,055) | | |
| Other income (loss): | | | | | | | |
|
Change in fair value of derivative warrant liabilities
|
| | | | (14,591,250) | | |
|
Financing costs - derivative warrant liabilities
|
| | | | (959,510) | | |
|
Investment income from the Trust Account
|
| | | | 11,767 | | |
|
Total other income (loss)
|
| | | | (15,538,993) | | |
|
Net loss
|
| | | $ | (15,887,048) | | |
|
Weighted average Class A ordinary shares outstanding, basic and diluted
|
| | | | 34,881,967 | | |
|
Basic and diluted net income per ordinary share, Class A
|
| | | $ | 0.00 | | |
|
Weighted average Class B ordinary shares outstanding, basic and diluted
|
| | | | 8,079,208 | | |
|
Basic and diluted net loss per ordinary share, Class B
|
| | | $ | (1.97) | | |
| | |
Preference
shares |
| |
Ordinary Shares
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Shareholders’ Equity |
| |||||||||||||||||||||||||||||||||||||||
|
Class A
|
| |
Class B
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||||
Balance – June 4, 2020 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Issuance of Class B ordinary shares to
sponsor |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 8,625,000 | | | | | | 863 | | | | | | 24,137 | | | | | | — | | | | | | 25,000 | | |
Sale of units in initial public offering, less fair value
of public warrants |
| | | | — | | | | | | — | | | | | | 34,500,000 | | | | | | 3,450 | | | | | | — | | | | | | — | | | | | | 326,366,550 | | | | | | — | | | | | | 326,370,000 | | |
Offering costs
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (18,670,336) | | | | | | — | | | | | | (18,670,336) | | |
Sale of private placement units, less fair value of private placement warrants
|
| | | | — | | | | | | — | | | | | | 1,062,500 | | | | | | 106 | | | | | | — | | | | | | — | | | | | | 9,764,264 | | | | | | — | | | | | | 9,764,370 | | |
Class A ordinary shares subject to possible redemption
|
| | | | — | | | | | | — | | | | | | (29,512,635) | | | | | | (2,951) | | | | | | — | | | | | | — | | | | | | (296,599,032) | | | | | | — | | | | | | (296,601,983) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (15,887,048) | | | | | | (15,887,048) | | |
Balance – December 31, 2020
|
| | | | — | | | | | $ | — | | | | | | 6,049,865 | | | | | $ | 605 | | | | | | 8,625,000 | | | | | $ | 863 | | | | | $ | 20,885,583 | | | | | $ | (15,887,048) | | | | | $ | 5,000,003 | | |
| Cash Flows from Operating Activities: | | | | | | | |
|
Net loss
|
| | | $ | (15,887,048) | | |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | |
|
Change in the fair value of derivative warrant liabilities
|
| | | | 14,591,250 | | |
|
Financing costs - derivative warrant liabilities
|
| | | | 959,510 | | |
|
Investment income from the Trust Account
|
| | | | (11,767) | | |
|
General and administrative expenses paid by sponsor in exchange for issuance of Class B ordinary shares
|
| | | | 19,800 | | |
|
General and administrative expenses paid by sponsor under promissory note
|
| | | | 11,055 | | |
| Changes in operating assets and liabilities: | | | | | | | |
|
Prepaid expenses
|
| | | | (136,636) | | |
|
Accounts payable
|
| | | | 9,352 | | |
|
Accrued expenses
|
| | | | 5,000 | | |
|
Net cash used in operating activities
|
| | | | (439,484) | | |
| Cash Flows from Investing Activities: | | | | | | | |
|
Cash deposited in Trust Account
|
| | | | (346,725,000) | | |
|
Net cash used in investing activities
|
| | | | (346,725,000) | | |
| Cash Flows from Financing Activities: | | | | | | | |
|
Proceeds from note payable to related party
|
| | | | 92,208 | | |
|
Repayment of note payable to related party
|
| | | | (188,213) | | |
|
Proceeds received from initial public offering, gross
|
| | | | 345,000,000 | | |
|
Proceeds received from private placement
|
| | | | 10,625,000 | | |
|
Offering costs paid
|
| | | | (7,389,696) | | |
|
Net cash provided by financing activities
|
| | | | 348,139,299 | | |
|
Net change in cash
|
| | | | 974,815 | | |
|
Cash – beginning of the period
|
| | |
|
—
|
| |
|
Cash – end of the period
|
| | | $ | 974,815 | | |
| Supplemental disclosure of noncash investing and financing activities: | | | | | | | |
|
Offering costs paid by sponsor in exchange for issuance of Class B ordinary shares
|
| | | $ | 5,200 | | |
|
Offering costs included in accrued expenses
|
| | | $ | 75,000 | | |
|
Offering costs funded with note payable
|
| | | $ | 84,950 | | |
|
Deferred underwriting commissions
|
| | | $ | 12,075,000 | | |
|
Initial value of Class A ordinary shares subject to possible redemption
|
| | | $ | 311,496,273 | | |
|
Change in initial value of Class A ordinary shares subject to possible redemption
|
| | | $ | (14,894,291) | | |
| | |
As of December 31, 2020
|
| |||||||||||||||
|
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
|
| |||||||||||
Balance Sheet | | | | | | | | | | | | | | | | | | | |
Total assets
|
| | | $ | 347,848,218 | | | | | $ | — | | | | | $ | 347,848,218 | | |
Liabilities and shareholders’ equity | | | | | | | | | | | | | | | | | | | |
Total current liabilities
|
| | | $ | 89,352 | | | | | $ | — | | | | | $ | 89,352 | | |
Deferred underwriting commissions
|
| | | | 12,075,000 | | | | | | — | | | | | | 12,075,000 | | |
Derivative warrant liabilities
|
| | | | — | | | | | | 34,081,880 | | | | | | 34,081,880 | | |
Total liabilities
|
| | | | 12,164,352 | | | | | | 34,081,880 | | | | | | 46,246,232 | | |
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity
|
| | | | 330,683,863 | | | | | | (34,081,880) | | | | | | 296,601,983 | | |
Preference shares – $0.0001 par value
|
| | | | — | | | | | | — | | | | | | — | | |
Class A ordinary shares – $0.0001 par value
|
| | | | 266 | | | | | | 339 | | | | | | 605 | | |
Class B ordinary shares – $0.0001 par value
|
| | | | 863 | | | | | | — | | | | | | 863 | | |
Additional paid-in-capital
|
| | | | 5,335,162 | | | | | | 15,550,421 | | | | | | 20,885,583 | | |
Accumulated deficit
|
| | | | (336,288) | | | | | | (15,550,760) | | | | | | (15,887,048) | | |
Total shareholders’ equity
|
| | | | 5,000,003 | | | | | | — | | | | | | 5,000,003 | | |
Total liabilities and shareholders’ equity
|
| | | $ | 347,848,218 | | | | | $ | — | | | | | $ | 347,848,218 | | |
| | |
Period From June 4, 2020 (Inception)
Through December 31, 2020 |
| |||||||||||||||
|
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
|
| |||||||||||
Statement of Operations | | | | | | | | | | | | | | | | | | | |
Loss from operations
|
| | | $ | (348,055) | | | | | $ | — | | | | | $ | (348,055) | | |
Other (expense) income:
|
| | | | | | | | | | | | | | | | | | |
Change in fair value of derivative warrant
liabilities |
| | | | — | | | | | | (14,591,250) | | | | | | (14,591,250) | | |
Financing cost – derivative warrant liabilities
|
| | | | — | | | | | | (959,510) | | | | | | (959,510) | | |
| | |
Period From June 4, 2020 (Inception)
Through December 31, 2020 |
| |||||||||||||||
|
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
|
| |||||||||||
Net gain from investments held in Trust Account
|
| | | | 11,767 | | | | | | — | | | | | | 11,767 | | |
Total other (expense) income
|
| | | | 11,767 | | | | | | (15,550,760) | | | | | | (15,538,993) | | |
Net loss
|
| | | $ | (336,288) | | | | | $ | (15,550,760) | | | | | $ | (15,887,048) | | |
Basic and Diluted weighted-average Class A ordinary
shares outstanding |
| | | | 34,881,967 | | | | | | — | | | | | | 34,881,967 | | |
Basic and Diluted net loss per Class A share
|
| | | $ | 0.00 | | | | | $ | — | | | | | $ | 0.00 | | |
Basic and Diluted weighted-average Class B ordinary shares outstanding
|
| | | | 8,079,208 | | | | | | — | | | | | | 8,079,208 | | |
Basic and Diluted net loss per Class B share
|
| | | $ | (0.04) | | | | | $ | (1.92) | | | | | $ | (1.97) | | |
| | |
Period From June 4, 2020 (Inception)
Through December 31, 2020 |
| |||||||||||||||
|
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
|
| |||||||||||
Statement of Cash Flows | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (336,288) | | | | | $ | (15,550,760) | | | | | $ | (15,887,048) | | |
Change in fair value of derivative warrant
liabilities |
| | | $ | — | | | | | $ | 14,591,250 | | | | | $ | 14,591,250 | | |
Financing Costs – derivative warrant liabilities
|
| | | $ | — | | | | | $ | 959,510 | | | | | $ | 959,510 | | |
Initial value of Class A ordinary shares subject to possible redemption
|
| | | $ | 330,986,901 | | | | | $ | (19,490,628) | | | | | $ | 311,496,273 | | |
Change in fair value of Class A ordinary shares subject to possible redemption
|
| | | $ | (303,038) | | | | | $ | (14,591,253) | | | | | $ | (14,894,291) | | |
December 31, 2020
|
| ||||||||||||||||||
Description
|
| |
Quoted Prices in Active
Markets (Level 1) |
| |
Significant Other
Observable Inputs (Level 2) |
| |
Significant Other
Unobservable Inputs (Level 3) |
| |||||||||
Assets | | | | | | | | | | | | | | | | | | | |
Investments held in Trust Account
|
| | | $ | 346,736,767 | | | | | $ | — | | | | | $ | — | | |
Liabilities | | | | | | | | | | | | | | | | | | | |
Derivative warrant liabilities -Public Warrants
|
| | | $ | 32,775,000 | | | | | $ | — | | | | | $ | — | | |
Derivative warrant liabilities -Private Warrants
|
| | | $ | — | | | | | $ | — | | | | | $ | 1,306,880 | | |
| | |
Initial Value
(as of August 31, 2020) |
| |
December 31, 2020
|
| ||||||
Volatility
|
| | | | 20 – 26% | | | | | | 23 – 29% | | |
Share price
|
| | | $ | 9.41 | | | | | $ | 10.41 | | |
Risk-free rate
|
| | | | 0.33% | | | | | | 0.43% | | |
Dividend yield
|
| | | | 0.0% | | | | | | 0.0% | | |
|
Warrant liabilities at June 4, 2020 (inception)
|
| | | $ | — | | |
|
Issuance of Public and Private Warrants – Level 3
|
| | | | 19,490,630 | | |
|
Transfer of Public Warrants to Level 1
|
| | | | (19,147,500) | | |
|
Change in fair value of warrant liabilities – Level 3
|
| | | | 963,750 | | |
|
Warrant liabilities – Level 3, December 31, 2020
|
| | | $ | 1,306,880 | | |
| | |
As of September 30, 2020
|
| |||||||||||||||
|
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
|
| |||||||||||
Unaudited Condensed Balance Sheet | | | | | | | | | | | | | | | | | | | |
Total assets
|
| | | $ | 348,505,871 | | | | | $ | — | | | | | $ | 348,505,871 | | |
Liabilities and shareholders’ equity | | | | | | | | | | | | | | | | | | | |
Total current liabilities
|
| | | $ | 554,296 | | | | | $ | — | | | | | $ | 554,296 | | |
Deferred underwriting commissions
|
| | | | 12,075,000 | | | | | | — | | | | | | 12,075,000 | | |
Derivative warrant liabilities
|
| | | | — | | | | | | 20,024,060 | | | | | | 20,024,060 | | |
Total liabilities
|
| | | | 12,629,296 | | | | | | 20,024,060 | | | | | | 32,653,356 | | |
Class A ordinary shares, $0.0001 par value; shares
subject to possible redemption |
| | | | 330,876,572 | | | | | | (20,024,060) | | | | | | 310,852,512 | | |
shareholders’ equity
|
| | | | | | | | | | | | | | | | | | |
Preference shares – $0.0001 par value
|
| | | | — | | | | | | — | | | | | | — | | |
Class A ordinary shares – $0.0001 par value
|
| | | | 264 | | | | | | 199 | | | | | | 463 | | |
Class B ordinary shares – $0.0001 par value
|
| | | | 863 | | | | | | — | | | | | | 863 | | |
Additional paid-in-capital
|
| | | | 5,142,455 | | | | | | 1,492,741 | | | | | | 6,635,196 | | |
Accumulated deficit
|
| | | | (143,579) | | | | | | (1,492,940) | | | | | | (1,636,519) | | |
Total shareholders’ equity
|
| | | | 5,000,003 | | | | | | — | | | | | | 5,000,003 | | |
Total liabilities and shareholders’ equity
|
| | | $ | 348,505,871 | | | | | $ | — | | | | | $ | 348,505,871 | | |
| | |
Period From June 4, 2020 (Inception)
Through September 30, 2020 |
| |||||||||||||||
|
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
|
| |||||||||||
Unaudited Condensed Statement of Operations | | | | | | | | | | | | | | | | | | | |
Loss from operations
|
| | | $ | (148,400) | | | | | $ | — | | | | | $ | (148,400) | | |
Other (expense) income:
|
| | | | | | | | | | | | | | | | | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | (533,430) | | | | | | (533,430) | | |
Financing cost – derivative warrant liabilities
|
| | | | — | | | | | | (959,510) | | | | | | (959,510) | | |
Net gain from investments held in Trust Account
|
| | | | 4,821 | | | | | | — | | | | | | 4,821 | | |
Total other (expense) income
|
| | | | 4,821 | | | | | | (1,492,940) | | | | | | (1,488,119) | | |
Net loss
|
| | | $ | (143,579) | | | | | $ | (1,492,940) | | | | | $ | (1,636,519) | | |
Basic and Diluted weighted-average Class A ordinary
shares outstanding |
| | | | 32,884,274 | | | | | | | | | | | | 32,884,274 | | |
Basic and Diluted net loss per Class A share
|
| | | $ | — | | | | | | | | | | | $ | — | | |
Basic and Diluted weighted-average Class B ordinary
shares outstanding |
| | | | 8,625,000 | | | | | | | | | | | | 8,625,000 | | |
Basic and Diluted net loss per Class B share
|
| | | $ | (0.02) | | | | | $ | (1.80) | | | | | $ | (1.82) | | |
| | |
Period From June 4, 2020 (Inception)
Through September 30, 2020 |
| |||||||||||||||
|
As Previously
Reported |
| |
Restatement
Adjustment |
| |
As Restated
|
| |||||||||||
Unaudited Condensed Statement of Cash Flows | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (143,579) | | | | | $ | (1,492,940) | | | | | $ | (1,636,519) | | |
Change in fair value of derivative warrant liabilities
|
| | | $ | — | | | | | $ | 533,430 | | | | | $ | 533,430 | | |
Financing Costs – derivative warrant liabilities
|
| | | $ | — | | | | | $ | 959,510 | | | | | $ | 959,510 | | |
Initial value of Class A ordinary shares subject to possible redemption
|
| | | $ | 330,986,901 | | | | | $ | (19,490,628) | | | | | $ | 311,496,273 | | |
Change in fair value of Class A ordinary shares subject to possible redemption
|
| | | $ | (110,329) | | | | | $ | (533,434) | | | | | $ | (643,763) | | |
1 Year Burgundy Technology Acqu... Chart |
1 Month Burgundy Technology Acqu... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions